Baricitinib is used to treat arthritis, both alone and in combination with methotrexate. The compound is a reversible inhibitor of Janus kinase enzyme


Baricitinib is used to treat arthritis, both alone and in combination with methotrexate. The compound is a reversible inhibitor of Janus kinase enzymes. Baricinitib was approved for use in the EU in 2017, but the USFDA has refused to approve the drug, citing concerns over safety and dosage.


Size: 4002px × 4366px
Photo credit: © GREG WILLIAMS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: 3d, 3d-render, arthritis, background, baricitinib, chemical, chemistry, cut, cut-, cut-outs, cutout, cutouts, drug, label, labeled, labelled, medicinal, model, molecular, molecule, olumiant, outs, pharmaceutical, render, rendering, rheumatoid, structure, treatment, white